Clinical Trials in Precision Medicine

Please click here to register

October 13, 2022 – Virtual Event

GenomeWeb and The Precision Medicine Leaders’ Summit present the

Clinical Trials in Precision Medicine

as part of our comprehensive coverage of the Precision Medicine Continuum

Join us at the Clinical Trials in Precision Medicine Virtual Summit to hear how precision medicine is changing clinical trial design. The event will take place on October 13th, 2022, from 10:00 am to 2:00 pm EST.

Advances in human genome sequencing and molecular testing have upended the traditional framework of phase 1-3 clinical trials for “all comer” populations and have ushered in new strategies to shorten the time to approval while identifying populations most likely to benefit from a drug.

Precision medicine has fostered novel clinical trial designs (platform, basket, umbrella, etc.) that allow investigators to use molecular markers to identify responders to novel drugs, thereby improving the efficacy and safety of the approved therapy in its intended population. And in oncology, the advent of tumor-agnostic drug approvals based solely on biomarker status has challenged the traditional model of trials based on cancer type.

Best practices in this area are evolving rapidly as data are reviewed and protocols are vetted to select for the best design and execution strategies.

If you are a clinical trial investigator, clinical scientist, practicing clinician, or in regulatory affairs, you cannot miss our lineup of speakers who will address these points and more:

Topics to be discussed:

  • The role of comprehensive genomic profiling in clinical trial enrollment
  • Partnership strategies for companion diagnostics development
  • Trends in biomarker discovery and validation
  • Overcoming obstacles in patient recruitment for clinical trials
  • The role of electronic health records and decision support tools
  • Navigating the evolving regulatory landscape
  • Best practices for adaptive design
  • Endpoint assessment for clinical trials
  • Ethical considerations for basket and umbrella trials
  • Clinical trials for precision medicine outside oncology
  • The future of tumor-agnostic drug approvals
  • Insights from landmark precision oncology trials: NCI-MATCH, Lung-MAP, MYLUNG, and more
Register Now